1M6MYTD1Y5YMAX
Loading quotes...
Forecast
The analysts' average price target is €4.21 (-9.27%). The median is €4.20 (-9.48%).
| Buy |
4 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | September 2025 | |
|---|---|---|
| Revenue | 0 | - |
| Gross profit | 0 | - |
| Net profit | -8.84M | - |
| EBITDA | -8.83M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €574.58K |
Number of shares | 2.28M |
52-week high/low | €11.89 - €0.15 |
| Dividends | No |
Beta | 0.49 |
P/E ratio | -0.01 |
PEG ratio | 0.00 |
P/B ratio | 0.24 |
P/S ratio | 26.27 |
Company profile
| Name | PORTAGE BIOTECH Aktie |
| CEO | Brittany Kaiser |
| Employees | 22 |
